Could Exogenous Insulin Ameliorate the Metabolic Dysfunction Induced by Glucocorticoids and COVID-19?

The finding that high-dose dexamethasone improves survival in those requiring critical care due to COVID-19 will mean much greater usage of glucocorticoids in the subsequent waves of coronavirus infection. Furthermore, the consistent finding of adverse outcomes from COVID-19 in individuals with obes...

Descripción completa

Detalles Bibliográficos
Autores principales: Whyte, Martin Brunel, Vas, Prashanth R. J., Umpleby, Anne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249851/
https://www.ncbi.nlm.nih.gov/pubmed/34220705
http://dx.doi.org/10.3389/fendo.2021.649405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249851/
https://www.ncbi.nlm.nih.gov/pubmed/34220705
http://dx.doi.org/10.3389/fendo.2021.649405

Ejemplares similares